Birdwatch Note
2022-12-20 18:35:56 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Dr. Rachel Levine is a transgender woman. Her pronouns are she/her. https://www.npr.org/sections/health-shots/2022/04/29/1095227346/rachel-levine-calls-state-anti-lgbtq-bills-disturbing-and-dangerous-to-trans-you
Written by 464F514091F013106E190C712492FDDD7A2F35D38B0E762F31374CC21B9FD858
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1604979397844402181
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1605270795026018304
- noteId - 1605270795026018304
- participantId - 464F514091F013106E190C712492FDDD7A2F35D38B0E762F31374CC21B9FD858
- noteAuthorParticipantId -
- createdAtMillis - 1671561356682
- tweetId - 1604979397844402181
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Dr. Rachel Levine is a transgender woman. Her pronouns are she/her. https://www.npr.org/sections/health-shots/2022/04/29/1095227346/rachel-levine-calls-state-anti-lgbtq-bills-disturbing-and-dangerous-to-trans-you
Note Ratings
| rated at | rated by | |
| 2023-01-07 15:56:59 -0600 | 862E84AD6C488AB3037EAC4682346692F09F61D556BF80E01E4F8B21C28D08CA | Rating Details |
| 2022-12-21 07:59:47 -0600 | E747D5009C8EBE93253050353F70456DA03D22F843AE88D99E6CC32502ED5400 | Rating Details |
| 2023-01-07 15:56:59 -0600 | Rating Details | |
| 2022-12-21 07:59:47 -0600 | Rating Details |